SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-14-000963
Filing Date
2014-03-24
Accepted
2014-03-24 17:12:38
Documents
6
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K rare-10k_20131231.htm 10-K 4344715
2 EX-10.23 rare-ex10_20131231221.htm EX-10 114315
3 EX-31.1 rare-ex31_20131231258.htm EX-31 14578
4 EX-31.2 rare-ex31_20131231259.htm EX-31 13810
5 EX-32.1 rare-ex32_20131231260.htm EX-32 11161
6 GRAPHIC g20140324185856091200.jpg GRAPHIC 159865
  Complete submission text file 0001564590-14-000963.txt   4719975
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36276 | Film No.: 14713813
SIC: 2834 Pharmaceutical Preparations